ZNF787

Across TCGA pan-cancer cohorts, ZNF787 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated ZNF787 data layer compared with 4 for mutation status and 6 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ZNF787 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF787 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

ACC, KIRP, and LIHC are the cancer types where ZNF787 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.252	0.651	<.001	134	view →
KIRP	DFS	Tertile	All	0.830	0.961	.001	74	view →
LIHC	OS	Median	All	0.711	0.837	<.001	62	view →
LUAD	OS	Tertile	All	0.749	0.846	.003	43	view →
LGG	DFS	Median	All	0.652	0.827	<.001	42	view →
COAD	DFS	Median	IV	0.275	0.687	.002	34	view →
UCEC	DFS	Tertile	IV	0.691	0.226	.004	32	view →
UCS	OS	Median	II,III,IV	0.316	0.648	.017	30	view →
KIRC	DFS	Median	All	0.833	0.919	.018	25	view →
PRAD	DFS	Tertile	All	0.704	0.888	<.001	24	view →
ESCA	OS	Median	All	0.617	1.000	.009	23	view →
GBM	DFS	Median	All	0.378	0.191	.004	21	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

ZNF787–ACC (DFS)

Open the ACC breakdown →